JPS4843755B1 - - Google Patents

Info

Publication number
JPS4843755B1
JPS4843755B1 JP44050780A JP5078069A JPS4843755B1 JP S4843755 B1 JPS4843755 B1 JP S4843755B1 JP 44050780 A JP44050780 A JP 44050780A JP 5078069 A JP5078069 A JP 5078069A JP S4843755 B1 JPS4843755 B1 JP S4843755B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP44050780A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP44050780A priority Critical patent/JPS4843755B1/ja
Priority to IL33558A priority patent/IL33558A/xx
Priority to FI693710A priority patent/FI46259C/fi
Priority to GB62863/69A priority patent/GB1299198A/en
Priority to ES375013A priority patent/ES375013A1/es
Priority to DE19691965304 priority patent/DE1965304A1/de
Priority to FR6945316A priority patent/FR2027356A1/fr
Priority to IE1726/69A priority patent/IE33906B1/xx
Priority to BE743875D priority patent/BE743875A/xx
Priority to BG013676A priority patent/BG20615A3/xx
Priority to NL6919607A priority patent/NL6919607A/xx
Priority to DK689569A priority patent/DK129169B/da
Priority to BG015832A priority patent/BG17805A3/xx
Priority to CH760672A priority patent/CH539062A/de
Priority to CH1945469A priority patent/CH531564A/de
Priority to RO62025A priority patent/RO55813A/ro
Priority to AT1212169A priority patent/AT299449B/de
Priority to CA086,357A priority patent/CA955595A/en
Priority to US00049974A priority patent/US3794644A/en
Publication of JPS4843755B1 publication Critical patent/JPS4843755B1/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP44050780A 1968-12-30 1969-06-26 Pending JPS4843755B1 (enExample)

Priority Applications (19)

Application Number Priority Date Filing Date Title
JP44050780A JPS4843755B1 (enExample) 1969-06-26 1969-06-26
IL33558A IL33558A (en) 1968-12-30 1969-12-17 Antibiotic pyrrolo-benzodiazepine compound,its derivatives and processes for their production
FI693710A FI46259C (fi) 1968-12-30 1969-12-22 Menetelmä uusien terapeuttisesti arvokkaiden 11-alkyylioksi-1,2,3,10,1 1,11a-heksahydro-2-etyylideeni-7-metoksi-8-hydroksi-5H-pyrrolo/2,1-c/ /1,4/bentsodiatsepin-5-onien valmistamiseksi.
GB62863/69A GB1299198A (en) 1968-12-30 1969-12-24 Pyrrolobenzodiazepinone derivatives
ES375013A ES375013A1 (es) 1968-12-30 1969-12-29 Un procedimiento para la preparacion de un nuevo compuesto pirrolobenzodiazepinona.
DE19691965304 DE1965304A1 (de) 1968-12-30 1969-12-29 Benzdiazepinon-Verbindungen und Verfahren zu ihrer Herstellung
FR6945316A FR2027356A1 (en) 1968-12-30 1969-12-29 Benzodiazepinone antibiotics
IE1726/69A IE33906B1 (en) 1968-12-30 1969-12-30 Pyrrolobenzodiazepinone derivatives
BE743875D BE743875A (enExample) 1968-12-30 1969-12-30
BG013676A BG20615A3 (bg) 1968-12-30 1969-12-30 Метод за получаване на производни на 5н-пироло<2,1-с><1,4>- бензодиазепини - 5-он
NL6919607A NL6919607A (enExample) 1968-12-30 1969-12-30
DK689569A DK129169B (da) 1968-12-30 1969-12-30 Fremgangsmåde til fremstilling af pyrrolodiazepinon-derivater.
BG015832A BG17805A3 (bg) 1968-12-30 1969-12-30 Метод за получаване на производни на 5н-пироло(2,1-с) (1,4)бензодиазепини-5-он
CH760672A CH539062A (de) 1968-12-30 1969-12-30 Verfahren zur Herstellung neuer Hexahydropyrrolobenzodiazepinone
CH1945469A CH531564A (de) 1968-12-30 1969-12-30 Verfahren zur Herstellung neuer Hexahydropyrrolobenzodiazepinone
RO62025A RO55813A (enExample) 1968-12-30 1969-12-30
AT1212169A AT299449B (de) 1968-12-30 1969-12-30 Verfahren zur herstellung von neuen, antibiotisch wirksamen benzdiazepin-verbindungen
CA086,357A CA955595A (en) 1969-06-26 1970-06-23 Pyrrolo-benzodiazepinone compounds and process for their preparation
US00049974A US3794644A (en) 1969-06-26 1970-06-25 Pyrrolo-benzodiazepinone compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP44050780A JPS4843755B1 (enExample) 1969-06-26 1969-06-26

Publications (1)

Publication Number Publication Date
JPS4843755B1 true JPS4843755B1 (enExample) 1973-12-20

Family

ID=12868329

Family Applications (1)

Application Number Title Priority Date Filing Date
JP44050780A Pending JPS4843755B1 (enExample) 1968-12-30 1969-06-26

Country Status (3)

Country Link
US (1) US3794644A (enExample)
JP (1) JPS4843755B1 (enExample)
CA (1) CA955595A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5452930U (enExample) * 1977-09-20 1979-04-12
JPS6417566U (enExample) * 1987-07-23 1989-01-27

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164376A (en) * 1989-10-30 1992-11-17 Hoffmann-Laroche Inc. Method for treating retroviral infections with aryl-(2-pyrryl) keytone compound
US5141735A (en) * 1990-06-18 1992-08-25 Hoffman-La Roche, Inc. Substituted amino-benzodiazepines having anitviral activity
CN103068405A (zh) 2010-04-15 2013-04-24 西雅图基因公司 靶向吡咯并苯并二氮杂卓结合物
MX368648B (es) 2010-04-15 2019-10-09 Seattle Genetics Inc Pirrolobenzodiazepinas usadas para tratar enfermedades proliferativas.
US9399641B2 (en) 2011-09-20 2016-07-26 Medimmune Limited Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates
CA2850375C (en) 2011-10-14 2019-07-02 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
AU2012322934B2 (en) 2011-10-14 2016-09-08 Medimmune Limited Pyrrolobenzodiazepines
CA2850373C (en) 2011-10-14 2019-07-16 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
CA2850264C (en) 2011-10-14 2019-11-05 Medimmune Limited Pyrrolobenzodiazepines
EP2906297B1 (en) 2012-10-12 2017-12-06 ADC Therapeutics SA Pyrrolobenzodiazepine-antibody conjugates
PT2906253T (pt) 2012-10-12 2018-11-05 Medimmune Ltd Conjugados de anticorpo anti-psma de pirrolobenzodiazepina
DK2906298T3 (en) 2012-10-12 2018-12-17 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
WO2014057114A1 (en) 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Pyrrolobenzodiazepine-anti-psma antibody conjugates
BR112015008238A2 (pt) 2012-10-12 2017-11-28 Adc Therapeutics Sarl conjugados de pirrolbenzodiazepina-anticorpo anti-cd22
EP2906249B1 (en) 2012-10-12 2018-06-27 MedImmune Limited Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
DK2839860T3 (da) 2012-10-12 2019-06-17 Medimmune Ltd Pyrrolobenzodiazepiner og konjugater deraf
PT2906248T (pt) 2012-10-12 2019-03-04 Medimmune Ltd Pirrolobenzodiazepinas e conjugados das mesmas
KR101995620B1 (ko) 2012-10-12 2019-07-03 에이디씨 테라퓨틱스 에스에이 피롤로벤조디아제핀-항체 컨주게이트
WO2015052534A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
GB201317981D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
US10010624B2 (en) 2013-10-11 2018-07-03 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
WO2015052535A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CN107148285B (zh) 2014-11-25 2022-01-04 Adc治疗股份有限公司 吡咯并苯并二氮杂䓬-抗体缀合物
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
RS61795B1 (sr) 2017-02-08 2021-06-30 Adc Therapeutics Sa Konjugati pirolobenzodiazepin antitela
SMT202200490T1 (it) 2017-04-18 2023-01-13 Medimmune Ltd Coniugati di pirrolobenzodiazepina
WO2018193102A1 (en) 2017-04-20 2018-10-25 Adc Therapeutics Sa Combination therapy with an anti-axl antibody-drug conjugate
KR102442736B1 (ko) 2017-06-14 2022-09-16 에이디씨 테라퓨틱스 에스에이 항-cd19 adc의 투여를 위한 투약량 체제
SI3668874T1 (sl) 2017-08-18 2022-04-29 Medimmune Limited Pirolobenzodiazepinski konjugati
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CN113631560B (zh) 2019-03-15 2025-02-18 麦迪穆有限责任公司 氮杂环丁烷并苯并二氮杂䓬二聚体和用于治疗癌症的包含它们的缀合物

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5452930U (enExample) * 1977-09-20 1979-04-12
JPS6417566U (enExample) * 1987-07-23 1989-01-27

Also Published As

Publication number Publication date
US3794644A (en) 1974-02-26
CA955595A (en) 1974-10-01

Similar Documents

Publication Publication Date Title
AU2270770A (enExample)
AU465452B2 (enExample)
AU429630B2 (enExample)
AU5461069A (enExample)
BE735770A (enExample)
AU5712069A (enExample)
AU417208B2 (enExample)
CS153523B2 (enExample)
AU5113869A (enExample)
AU442554B2 (enExample)
AU428074B2 (enExample)
AU410358B2 (enExample)
AU442357B2 (enExample)
AU442535B2 (enExample)
AU425297B2 (enExample)
AU470661B1 (enExample)
AU442322B2 (enExample)
AU442380B2 (enExample)
AU438128B2 (enExample)
AT308690B (enExample)
AU442285B2 (enExample)
AU5228269A (enExample)
CS149294B1 (enExample)
AU6261969A (enExample)
CS148829B1 (enExample)